RXST

RxSight, Inc. NASDAQ Listed Jul 30, 2021

Healthcare ·Medical - Devices ·US · rxsight.com

$6.78

After hrs $6.54 -3.54%

Mkt Cap $279.8M

52w Low $5.90 8.1% of range 52w High $16.74

50d MA $7.20 200d MA $8.78

P/E (TTM) -7.8x

EV/EBITDA -10.6x

P/B 1.1x

Debt/Equity 0.0x

ROE -14.1%

P/FCF -22.2x

RSI (14) —

ATR (14) —

Beta 1.21

50d MA $7.20

200d MA $8.78

Avg Volume 876.2K

About

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light de…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	-0.33	-0.22	+34.3%	8.81	-13.6%	-10.1%	-15.1%	-13.6%	-13.5%	-10.0%	—
Nov 5, 2025	AMC	-0.19	-0.04	+78.9%	8.34	+18.7%	+3.2%	+12.4%	+21.2%	+22.7%	+20.0%	—
Aug 7, 2025	AMC	-0.10	-0.08	+20.0%	7.79	-4.4%	-7.7%	-14.6%	-5.6%	+6.7%	+5.5%	—
May 7, 2025	AMC	-0.04	-0.03	+25.0%	14.90	+3.4%	-11.2%	-12.3%	-7.7%	-11.4%	-11.1%	—
Feb 25, 2025	AMC	0.10	0.03	-70.0%	29.21	-6.1%	-0.8%	-3.4%	-2.9%	-7.8%	-8.0%	—
Nov 7, 2024	AMC	-0.25	-0.16	+36.0%	50.85	-7.5%	-5.6%	-8.9%	-10.6%	-12.2%	-13.2%	—
Aug 5, 2024	AMC	-0.22	-0.16	+27.3%	40.78	+23.6%	+17.3%	+13.4%	+21.0%	+24.4%	+27.9%	—
May 6, 2024	AMC	-0.17	-0.12	+29.4%	62.84	+5.9%	-1.0%	-3.5%	-2.3%	-5.6%	-6.4%	—
Feb 28, 2024	AMC	-0.36	-0.26	+27.8%	56.39	+2.4%	-3.2%	-1.2%	-0.6%	-3.4%	-4.7%	—
Nov 9, 2023	AMC	-0.42	-0.35	+16.7%	23.80	-1.2%	+6.2%	+8.7%	+14.3%	+15.4%	+18.2%	—
Aug 7, 2023	AMC	-0.47	-0.40	+14.9%	28.84	+11.0%	+2.7%	-4.2%	-3.1%	-2.3%	+2.5%	—
May 9, 2023	AMC	-0.52	-0.42	+19.2%	19.25	+3.9%	+9.9%	+14.1%	+19.3%	+17.6%	+22.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 9	Stifel	Maintains	Hold → Hold	—	$7.69	$7.36	-4.3%	-1.6%	-2.3%	-3.9%	-0.7%	-4.7%
Feb 26	UBS	Maintains	Neutral → Neutral	—	$8.81	$7.61	-13.6%	-10.1%	-15.1%	-13.6%	-13.5%	-10.0%
Feb 26	Piper Sandler	Maintains	Neutral → Neutral	—	$8.81	$7.61	-13.6%	-10.1%	-15.1%	-13.6%	-13.5%	-10.0%
Feb 26	Needham	Maintains	Buy → Buy	—	$8.81	$7.61	-13.6%	-10.1%	-15.1%	-13.6%	-13.5%	-10.0%
Jan 20	Piper Sandler	Maintains	Neutral → Neutral	—	$9.81	$9.79	-0.2%	-1.5%	+1.4%	+0.5%	-3.1%	-2.7%
Dec 2	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$11.65	$11.52	-1.1%	+0.9%	+1.8%	+7.2%	+8.4%	+7.8%
Nov 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$8.34	$9.90	+18.7%	+3.2%	+12.4%	+21.2%	+22.7%	+20.0%
Nov 6	Needham	Maintains	Buy → Buy	—	$8.34	$9.90	+18.7%	+3.2%	+12.4%	+21.2%	+22.7%	+20.0%
Nov 6	JP Morgan	Maintains	Underweight → Underweight	—	$8.34	$9.90	+18.7%	+3.2%	+12.4%	+21.2%	+22.7%	+20.0%
Aug 8	UBS	Maintains	Neutral → Neutral	—	$7.79	$7.45	-4.4%	-7.7%	-14.6%	-5.6%	+6.7%	+5.5%
Aug 8	Stifel	Maintains	Hold → Hold	—	$7.79	$7.45	-4.4%	-7.7%	-14.6%	-5.6%	+6.7%	+5.5%
Aug 8	Needham	Maintains	Buy → Buy	—	$7.79	$7.45	-4.4%	-7.7%	-14.6%	-5.6%	+6.7%	+5.5%
Jul 15	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$7.74	$7.62	-1.6%	-3.7%	-5.9%	-4.7%	-5.0%	-5.0%
Jul 10	Jefferies	Downgrade	Buy → Hold	—	$7.95	$7.97	+0.3%	+6.4%	+0.6%	-2.6%	-6.3%	-8.4%
Jul 9	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
Jul 9	BofA Securities	Maintains	Underperform → Underperform	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
Jul 9	Stifel	Maintains	Hold → Hold	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
Jul 9	Piper Sandler	Maintains	Neutral → Neutral	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
Jul 9	Needham	Maintains	Buy → Buy	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
Jul 9	BTIG	Downgrade	Buy → Neutral	—	$12.79	$6.44	-49.6%	-37.8%	-33.9%	-37.5%	-39.5%	-41.8%
May 19	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$14.19	$15.39	+8.5%	+15.0%	+17.1%	+12.8%	+12.0%	+10.5%
Apr 9	UBS	Downgrade	Buy → Neutral	—	$14.99	$14.36	-4.2%	+3.5%	-5.3%	-6.1%	-3.8%	-2.5%
Apr 8	Needham	Maintains	Buy → Buy	—	$16.61	$17.29	+4.1%	-9.8%	-6.6%	-14.6%	-15.2%	-13.2%
Apr 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$16.26	$15.42	-5.2%	+2.2%	-7.8%	-4.6%	-12.7%	-13.4%
Apr 4	JP Morgan	Downgrade	Overweight → Underweight	—	$16.21	$15.17	-6.4%	+0.3%	+2.5%	-7.5%	-4.3%	-12.5%
Apr 3	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$26.12	$16.00	-38.7%	-37.9%	-37.7%	-36.4%	-42.6%	-40.6%
Apr 3	Needham	Maintains	Buy → Buy	—	$26.12	$16.00	-38.7%	-37.9%	-37.7%	-36.4%	-42.6%	-40.6%
Mar 21	BofA Securities	Maintains	Buy → Buy	—	$24.90	$24.35	-2.2%	-0.2%	+0.1%	-0.8%	-2.1%	+7.1%
Mar 19	Stifel	Maintains	Hold → Hold	—	$25.73	$25.41	-1.2%	-3.4%	-3.2%	-3.5%	-3.1%	-4.0%
Feb 26	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$29.21	$27.44	-6.1%	-0.8%	-3.4%	-2.9%	-7.8%	-8.0%
Feb 26	Stifel	Maintains	Hold → Hold	—	$29.21	$27.44	-6.1%	-0.8%	-3.4%	-2.9%	-7.8%	-8.0%
Feb 26	Needham	Maintains	Buy → Buy	—	$29.21	$27.44	-6.1%	-0.8%	-3.4%	-2.9%	-7.8%	-8.0%
Feb 26	JP Morgan	Maintains	Overweight → Overweight	—	$29.21	$27.44	-6.1%	-0.8%	-3.4%	-2.9%	-7.8%	-8.0%
Jan 13	Stifel	Maintains	Hold → Hold	—	$33.43	$32.66	-2.3%	-8.1%	-10.0%	-6.3%	-6.7%	-9.1%
Jan 13	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$33.43	$32.66	-2.3%	-8.1%	-10.0%	-6.3%	-6.7%	-9.1%
Jan 13	Needham	Maintains	Buy → Buy	—	$33.43	$32.66	-2.3%	-8.1%	-10.0%	-6.3%	-6.7%	-9.1%
Dec 20	Stifel	Downgrade	Buy → Hold	—	$38.19	$35.41	-7.3%	-11.9%	-9.4%	-9.7%	-8.2%	-10.4%
Dec 17	Needham	Maintains	Buy → Buy	—	$38.49	$38.30	-0.5%	-1.2%	-3.4%	-0.8%	-12.5%	-10.1%
Dec 11	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$39.17	$37.51	-4.2%	-4.1%	-8.4%	-4.8%	-1.7%	-2.9%
Sep 13	Needham	Maintains	Buy → Buy	—	$54.54	$54.83	+0.5%	+0.8%	+1.8%	+2.9%	-0.7%	-1.8%
Aug 20	Needham	Maintains	Buy → Buy	—	$52.83	$53.89	+2.0%	+1.8%	+1.6%	+2.8%	+6.9%	+5.7%
Aug 6	Needham	Maintains	Buy → Buy	—	$40.78	$50.41	+23.6%	+17.3%	+13.4%	+21.0%	+24.4%	+27.9%
Aug 6	Stifel	Maintains	Buy → Buy	—	$40.78	$50.41	+23.6%	+17.3%	+13.4%	+21.0%	+24.4%	+27.9%
Aug 6	Wells Fargo	Maintains	Overweight → Overweight	—	$40.78	$50.41	+23.6%	+17.3%	+13.4%	+21.0%	+24.4%	+27.9%
Aug 6	Oppenheimer	Maintains	Outperform → Outperform	—	$40.78	$50.41	+23.6%	+17.3%	+13.4%	+21.0%	+24.4%	+27.9%
Jul 15	BTIG	Maintains	Buy → Buy	—	$47.72	$48.95	+2.6%	+1.9%	+3.6%	-1.0%	-3.5%	-2.0%
Jul 10	Stifel	Maintains	Buy → Buy	—	$56.99	$55.89	-1.9%	-10.3%	-12.7%	-16.3%	-14.7%	-13.3%
May 7	Needham	Maintains	Buy → Buy	—	$62.84	$66.54	+5.9%	-1.0%	-3.5%	-2.3%	-5.6%	-6.4%
May 7	BTIG	Maintains	Buy → Buy	—	$62.84	$66.54	+5.9%	-1.0%	-3.5%	-2.3%	-5.6%	-6.4%
May 7	Wells Fargo	Maintains	Overweight → Overweight	—	$62.84	$66.54	+5.9%	-1.0%	-3.5%	-2.3%	-5.6%	-6.4%

Recent Filings

8-K

Unknown — 8-K Filing

A four-year vesting schedule for executive options incentivizes long-term retention at RXST, reducing near-term dilution while aligning management's interests with sustained stock performance.

Mar 19

8-K

RxSight, Inc. -- 8-K Filing

RxSight's 2025 LAL (light-adjustable lens) revenue grew strongly year-over-year, indicating successful market adoption and physician acceptance of their differentiated ophthalmic technology.

Feb 25

Data updated apr 26, 2026 11:50pm · Source: massive.com